DPharm: Disruptive Innovations Speakers
Andreas Koester, MD, PhD
Vice President, Clinical Trial Innovation & External Alliances
Janssen, Pharmaceutical Companies of Johnson & Johnson
Andreas Koester has more than 20 years of R&D experience working for pharmaceutical companies and CROs (Contract Research Organizations).
Currently, he is Head of Clinical Trial Innovation and External Alliances at Janssen Research & Development, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this recently created role, Andreas is leading the company’s efforts to enhance and optimize pharmaceutical clinical trials. He is also leading industry-wide efforts to define opportunities for collaboration in the pre-competitive space.
His background is in drug development, spanning first in human, proof of concept and large registration trials. He worked in leadership roles for trials that led to approvals of Prezista®, Intelence® and Reminyl®. Andreas is a graduate of Leipzig Medical School and earned his Ph.D. in Clinical Pharmacology from Humboldt University in Berlin.